The Blood Glucose Test Strip Market Is Estimated To Witness High Growth Owing To Increasing Diabetes Prevalence
The blood glucose test strip market is estimated to be valued at US$ 10.7 Bn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The blood glucose test strip market provides test strips that are used in glucose monitoring devices to measure the blood glucose levels. These strips help diabetes patients monitor their blood glucose levels on a regular basis to manage their condition. The key product types include coated enzyme test strips, metal-enzyme test strips, and others. The coated enzyme test strips hold the largest market share due to their high accuracy and easy readability of results. Common applications of blood glucose test strips include self/home healthcare, hospitals, and others.
Market Dynamics:
Increasing prevalence of diabetes worldwide is a key factor driving growth of the blood glucose test strip market. As per the International Diabetes Federation (IDF), around 537 million adults were living with diabetes in 2021 worldwide which is projected to reach 643 million by 2030 and 783 million by 2045. Moreover, rising geriatric population who are more prone to diabetes also supports growth of the market. For instance, as per WHO, the geriatric population (aged 65 years or older) is projected to grow nearly twice as fast as the overall world population between 2015 and 2050.
However, alternative methods for glucose monitoring such as continuous glucose monitoring systems and non-invasive glucose monitoring systems pose significant competition to test strips and hinder the market growth. Nevertheless, growing awareness regarding diabetes self-management and technological advancements in test strip design are expected to create lucrative opportunities over the forecast period.
SWOT Analysis
Strength: Blood glucose test strip has high accuracy and reliability for self-monitoring of blood glucose levels. The strips are compact, easy to use and provide fast results. Test strips offer painless and minimally invasive blood collection method. Availability of advanced blood glucose test strips with additional features such as Bluetooth connectivity and cloud storage is gaining popularity.
Weakness: Repeated pricking of fingers multiple times a day can cause discomfort, pain and skin irritation over time. Storage and handling of test strips require attention as strips can get exposed to moisture, heat and contamination affecting results accuracy. Availability of low-cost alternatives and counterfeit products in some regions is a challenge.
Opportunity: Rising prevalence of diabetes worldwide especially in developing nations presents huge market potential. Growing geriatric population and increasing health awareness drives the demand. Technological advancements to develop innovative test strips with additional diagnostics, connectivity and cloud-based features provide new opportunities.
Threats: Stringent regulations for product approval delays market access. Reimbursement policies vary significantly across regions posing challenges. Economic slowdowns can decrease discretionary healthcare spending affecting sales. Intense competition leads to pricing pressures.
Key Takeaways
The Global Blood Glucose Test Strip Market Size is expected to witness high growth, exhibiting CAGR of 7.4% over the forecast period, due to increasing prevalence of diabetes globally. As per International Diabetes Federation, approximately 537 million adults aged 20-79 years were living with diabetes in 2021 and the number is projected to rise to 643 million by 2030 and 783 million by 2045.
Regional analysis: North America currently dominates the global market owing to supportive insurance coverage and accessibility of advanced technologies. However, Asia Pacific is poised to be the fastest growing region attributed to rising diabetes patient pool, growing health awareness and improving access to diagnosis and treatment in developing nations.
Key players analysis: Key players operating in the blood glucose test strip market are Abbott, F. Hoffmann-La Roche Ltd, Johnson & Johnson, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, AgaMatrix, Bionime Corporation, ACON Laboratories, Inc., MEDISANA GMBH, Tividia Health, Inc. and Rossmax International Ltd. Major players focus on new product launches, technological advancements and geographical expansion strategies to strengthen their market presence.